Long Term Administration of Nivolumab for Metastatic Melanoma: A Case Report

The treatment of metastatic melanoma changed dramatically with the discovery of immune checkpoint inhibitors (ICIs). Patients face prolonged exposure to these agents, which can frequently generate a large spectrum of adverse reactions. It has been shown that a considerable number of patients treated...

Descripción completa

Detalles Bibliográficos
Autores principales: Oprea, Adela-Raluca, Benas, Arnaud, Havasi, Andrei, Gorzo, Alecsandra, Spinu, Stefan, Sur, Daniel, Burz, Claudia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2022
Materias:
Dermatology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9329602/
https://www.ncbi.nlm.nih.gov/pubmed/35911362
http://dx.doi.org/10.7759/cureus.26359

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9329602/
https://www.ncbi.nlm.nih.gov/pubmed/35911362
http://dx.doi.org/10.7759/cureus.26359

Ejemplares similares